Senores Pharmaceuticals Limited, established in December 2017, is a global pharmaceutical company specializing in the development and manufacturing of complex generic medications. The company focuses on creating affordable, high-quality pharmaceutical products certified by global food and drug authorities, aiming to enhance healthcare accessibility worldwide. Manufacturing and Facilities: Senores operates three manufacturing facilities, including a USFDA-approved oral solid dosage plant in Atlanta, USA, and an API & Intermediates manufacturing plant. These facilities adhere to stringent regulatory standards, ensuring the production of high-quality pharmaceutical products. Product Portfolio: The company’s product selection strategy…
Read MoreSenores Pharmaceuticals Limited IPO
